New York state is calling for proposals for developers to build a 200,000-square-foot cell and gene therapy hub.

Here are the top 25 cancer stories Becker's reported on in 2023:

Welireg (belzutifan), a Merck drug co-developed by researchers at Dallas-based UT Southwestern Medical Center, gained a new approval Dec. 14.

Syracuse, N.Y.-based St. Joseph's Health is partnering with Roswell Park Comprehensive Cancer Center in Buffalo, N.Y., to bring more oncology services to local residents.

Indianapolis-based Community Health Network is adding two cancer treatments to its cancer center thanks to a partnership with Houston-based MD Anderson Cancer Center, Inside Indiana Business reported Dec. 14.

UChicago Medicine has received a $20 million gift to support the development of a cancer care and research facility that's slated to open in 2027. 

A new year means new goals and strategies for cancer centers across the nation.

Kennewick, Wash.-based Trios Health will temporarily end its medical oncology services Dec. 13 due to staff shortages, the Tri-City Herald reported.

New Brunswick-based Rutgers Cancer Institute of New Jersey and RWJBarnabas Health in West Orange, N.J., have named Louise Ligresti, MD, as chief of cancer survivorship.

A recent analysis found multiple myeloma patients in real-world settings have worse outcomes from standard regimens compared to those reported in clinical trials.

A study by New York City-based NYU Langone Health found a combination of a drug and protein fragment that prevents the growth of blood cancer cells.

With 16 cancer drugs currently on the FDA's drug shortage list, Jason Westin, MD, the director of Houston-based MD Anderson Cancer Center's Lymphoma Clinical Research Program, section chief for Aggressive Lymphoma, told the Senate Finance Committee Dec. 5 that "providers shouldn't have to make impossible choices about patient care."

Atlanta-based Piedmont Oncology Institute named Walter Curran Jr., MD, its new chief.

Doris Ranski-Zazula, BSN, RN, was appointed vice president of the Detroit-based Karmanos Cancer Network, part of McLaren Health Care. 

Researchers at Santa Monica, Calif.-based Providence Saint John’s Health Center published new findings from a clinical trial that shed light on a possible treatment for a rare spine cancer.

A partnership between Durham, N.C.,-based Duke University School of Medicine and Houston-based University of Texas MD Anderson Cancer Center has led to the early discovery of a potential method that may be capable of protecting bones from damage during cancer treatments.

LSU Health, LCMC Health, Louisiana Cancer Research Center and Tulane University, all based in New Orleans, are collaborating to bring the state's first National Cancer Institute-designated cancer center, but recruitment efforts stand in the way, nola.com reported Dec. 4.

Atlanta-based Emory University has selected Sandra Wong, MD, a surgical oncologist, to lead as the next dean of Emory University School of Medicine and chief academic officer for Emory Healthcare. 

The Medical Board of California revoked the license of an oncologist who provided "sham treatment" to 1,000 patients, the San Francisco Chronicle reported Nov. 30.

Patients who have a cancer diagnosis and also struggle to find the financial means to pay for needed oncology services tend to have worse outcomes, according to the Association of Community Cancer Centers. Connecting the dots for those patients is the impetus behind the group's newly updated guidelines which are designed to aid programs in determining which patients may need this kind of assistance.